Related references
Note: Only part of the references are listed.Limitations of subgroup analysis of underpowered clinical trials for making causal inference about treatment effects
Milad Nazarzadeh et al.
EUROPEAN HEART JOURNAL (2020)
Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC)
Kazem Rahimi et al.
BMJ OPEN (2019)
Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: a retrospective cohort study
Emily Herrett et al.
LANCET (2019)
Long-Term Exposure to Elevated Systolic Blood Pressure in Predicting Incident Cardiovascular Disease: Evidence From Large-Scale Routine Electronic Health Records
Jose Roberto Ayala Solares et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Systolic Blood Pressure and Risk of Valvular Heart Disease: A Mendelian Randomization Study
Milad Nazarzadeh et al.
JAMA CARDIOLOGY (2019)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/N MA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data
Kunal N. Karmali et al.
PLOS MEDICINE (2018)
Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels A Systematic Review and Meta-analysis
Mattias Brunstrom et al.
JAMA INTERNAL MEDICINE (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
Elevated blood pressure and risk of aortic valve disease: a cohort analysis of 5.4 million UK adults
Kazem Rahimi et al.
EUROPEAN HEART JOURNAL (2018)
Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials
Michael Boehm et al.
LANCET (2017)
Elevated blood pressure and risk of mitral regurgitation: A longitudinal cohort study of 5.5 million United Kingdom adults
Kazem Rahimi et al.
PLOS MEDICINE (2017)
Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study
Emmanuelle Vidal-Petiot et al.
LANCET (2016)
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
Dena Ettehad et al.
LANCET (2016)
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease
Eva M. Lonn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Effects of Blood Pressure Reduction in Mild Hypertension A Systematic Review and Meta-analysis
Johan Sundstrom et al.
ANNALS OF INTERNAL MEDICINE (2015)
The Epidemiology of Blood Pressure and Its Worldwide Management
Kazem Rahimi et al.
CIRCULATION RESEARCH (2015)
Effect of antihypertensive agents on risk of atrial fibrillation: a meta-analysis of large-scale randomized trials
Connor A. Emdin et al.
EUROPACE (2015)
Usual Blood Pressure and Risk of New-Onset Diabetes Evidence From 4.1 Million Adults and a Meta-Analysis of Prospective Studies
Connor A. Emdin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
Jackson T. Wright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data
LANCET (2014)
Blood Pressure Management in the 21st Century Maximizing Gains and Minimizing Waste
Kazem Rahimi et al.
CIRCULATION (2013)
The J-Curve Between Blood Pressure and Coronary Artery Disease or Essential Hypertension Exactly How Essential?
Franz H. Messerli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Statistics in medicine - Reporting of subgroup analyses in clinical trials
Rui Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A comparison of methods for fixed effects meta-analysis of individual patient data with time to event outcomes
Catrin Tudur Smith et al.
CLINICAL TRIALS (2007)
Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients
H Suzuki et al.
HYPERTENSION RESEARCH (2005)
Preventing microalbuminuria in type 2 diabetes
P Ruggenenti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker
MS Pepe et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
